Header

UZH-Logo

Maintenance Infos

Publications for Asmis, L

Navigate back| Up a level
Export as
Group by:
Number of items: 9.

2017

Studt, J D; Alberio, L; Angelillo-Scherrer, A; Asmis, L M; Fontana, P; Korte, W; Mendez, A; Schmid, P; Stricker, H; Tsakiris, D A; Wuillemin, W A; Nagler, Michael (2017). Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels. Journal of Thrombosis and Haemostasis, 15(8):1576-1583.

Bulla, O; Poncet, A; Albeiro, L; Asmis, L M; Gähler, A; Graf, L; Nagler, M; Studt, J D; Tsakiris, D A; Fontana, P (2017). Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study. Haemophilia, 23(4):e335-e339.

Fontana, Pierre; Alberio, Lorenzo; Angelillo-Scherrer, Anne; Asmis, Lars M; Korte, Wolfgang; Mendez, Adriana; Schmid, Pirmin; Stricker, Hans; Studt, Jan-Dirk; Tsakiris, Dimitrios A; Wuillemin, Walter A; Nagler, Michael (2017). Impact of rivaroxaban on point-of-care assays. Thrombosis research, 153:65-70.

2016

Cushing, Melissa M; Asmis, Lars; Calabia, Carmencita; Rand, Jacob H; Haas, Thorsten (2016). Efficacy of solvent/detergent plasma after storage at 2-8 °C for 5 days in comparison to other plasma products to improve factor V levels in factor V deficient plasma. Transfusion and Apheresis Science, 55(1):114-119.

2015

Haas, T; Fries, D; Tanaka, K A; Asmis, L; Curry, N S; Schöchl, H (2015). Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? British Journal of Anaesthesia, 114(2):217-224.

2010

Asmis, L; Tanner, F C; Sudano, I; Lüscher, T F; Camici, G G (2010). DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents? Biochemical and Biophysical Research Communications (BBRC), 391(4):1629-16333.

Asmis, L. On Hyper & Hypocoagulable States. 2010, University of Zurich, Faculty of Medicine.

2009

Seeger, H; Asmis, L; Husmann, M (2009). Management venöser Thromboembolien. Praxis, 98(14):735-746.

2008

Ulrich, S; Brand, B; Speich, R; Oldenburg, J; Asmis, L (2008). Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland. Swiss Medical Weekly, 138(7-8):100-107.

This list was generated on Sat Dec 16 05:01:08 2017 CET.